Chemodenervation

Chemodenervation is a term frequently used to describe the use of Botulinum Toxin to treat various forms of neurological conditions. Botulinum Toxin is a natural bacterium produced protein neurotoxin called “Clostirium Botulinum.” It is used to immobilize overactive muscle movements by blocking nerve signals sent from the brain. These nerve signals are instructing the muscles to contract, generating irrepressible spasms. Physicians may use Chemodenervation to reduce symptoms of cerebral palsy, spasmodic torticollis, dystonia and other movement disorders.

The neurotoxin is injected directly into the muscle tissue to weaken excessive activity in specific focal areas. The injection is presented in small doses avoiding any risk of paralysis. When the muscles are relaxed they are no longer able to contract therefore preventing the uncontrollable spasms.

    Related Conference of Chemodenervation

    February 05-06, 2026

    9th Annual Conference on Skin Cancer and Dermatology

    Paris, France
    April 16-17, 2026

    9th World Cosmetic and Dermatology Congress

    Paris, France
    June 15-16, 2026

    COSMETIC DERMATOLOGY 2026

    Paris, France
    June 22-23, 2026

    28th World Dermatology and Aesthetic Congress

    London, UK
    June 25-26, 2026

    27th World Dermatology Congress

    Paris, France
    July 20-21, 2026

    20th International Conference on Alzheimers Disease & Dementia

    Amsterdam, Netherlands
    August 25-26, 2026

    26th European Dermatology Congress

    Paris, France
    September 23-24, 2026

    9th International Dermatology Conference: Skin and Body

    Barcelona, Spain

    Chemodenervation Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in